Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Clinical trial NCT06113081 · COMPLETED

Trial details

NCT number: NCT06113081
Sponsor: Fondazione Italiana Linfomi - ETS
Status: COMPLETED
Study type: OBSERVATIONAL

Cutaneous T Cell Lymphoma Cutaneous T-Cell Lymphoma/Mycosis Fungoides Cutaneous T-Cell Lymphoma/Sezary Syndrome

Start date: 2024-06-06
Primary completion: 2025-10-10
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.